UTI Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8357 Cr | ₹1119 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 28% |
Expense Ratio | 1.82 | 2.22 |
Manager | Sailesh Raj Bhan | Kamal Gada |
ISIN Code | INF204K01968 | INF789F01695 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | -1.7% | -1.28% |
6 Month | 8.28% | 12.46% |
1 Year | -3.42% | 0.95% |
3 Year | 21.74% | 25.1% |
5 Year | 17.15% | 17.28% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | 0.92% | 2.86% |
1 Year | 6.32% | 11.35% |
3 Year | 19.06% | 24.03% |
5 Year | 17.23% | 19.58% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 16.99% | 11.94% |
3 Year | 20.8% | 16.4% |
5 Year | 20.54% | 14.62% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 15.22% | 15.78% |
Sharp | 0.89% | 1.02% |
Beta | 0.91% | 0.95% |
Alpha | -0.46% | 1.53% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Sailesh Raj Bhan | Kamal Gada |
Total AUM | ₹96086 Cr | ₹870 Cr |
Funds Managed | 5 | 1 |
Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 1.56 | 3.78 |
Large Cap | 34.91 | 22.86 |
Mid Cap | 32.08 | 33.45 |
Small Cap | 31.46 | 39.91 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 0.52 | 0.65 |
Healthcare | 99.48 | 98.23 |
Basic Materials | - | 1.12 |
Top Comparisons
Nippon India Low Duration Fund - Retail Plan - Growth Plan - Growth Option
3Y Returns7.05%
Nippon India Low Duration Fund- Growth Plan - Growth Option
3Y Returns7.21%
Aditya Birla Sun Life Global Emerging Opportunities Fund - Regular Plan - Growth Option
3Y Returns17.9%
Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth
3Y Returns38.27%
ICICI Prudential Manufacturing Fund - Growth Option
3Y Returns26.72%
Tata Ethical Fund-Regular Plan - Growth Option
3Y Returns11.08%
Mahindra Manulife Equity Savings Fund - Regular Plan - Growth
3Y Returns10.09%
UTI Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns11.17%